Mirabella, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 8.610
EU - Europa 7.305
AS - Asia 6.778
SA - Sud America 1.493
AF - Africa 210
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 24.433
Nazione #
US - Stati Uniti d'America 8.391
SG - Singapore 3.207
DE - Germania 2.714
CN - Cina 1.522
BR - Brasile 1.219
SE - Svezia 1.196
IT - Italia 715
VN - Vietnam 614
FR - Francia 550
UA - Ucraina 456
IE - Irlanda 338
FI - Finlandia 314
GB - Regno Unito 307
IN - India 261
ID - Indonesia 229
PL - Polonia 214
JP - Giappone 171
RU - Federazione Russa 159
HK - Hong Kong 150
AR - Argentina 100
BD - Bangladesh 97
IQ - Iraq 95
TR - Turchia 88
CA - Canada 85
MX - Messico 61
AT - Austria 59
NL - Olanda 57
ZA - Sudafrica 56
KR - Corea 53
CI - Costa d'Avorio 50
BE - Belgio 44
EC - Ecuador 40
ES - Italia 36
PK - Pakistan 36
VE - Venezuela 32
CO - Colombia 30
IR - Iran 30
SA - Arabia Saudita 30
UZ - Uzbekistan 24
MA - Marocco 22
CL - Cile 21
JO - Giordania 21
PY - Paraguay 19
AU - Australia 17
CH - Svizzera 16
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 15
KE - Kenya 15
TN - Tunisia 15
CZ - Repubblica Ceca 14
DO - Repubblica Dominicana 14
RO - Romania 14
PE - Perù 13
DZ - Algeria 12
LT - Lituania 12
IL - Israele 11
KZ - Kazakistan 11
PT - Portogallo 11
UY - Uruguay 11
EG - Egitto 10
PA - Panama 10
PH - Filippine 10
JM - Giamaica 9
MY - Malesia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BO - Bolivia 8
GR - Grecia 8
HU - Ungheria 8
NP - Nepal 8
PS - Palestinian Territory 8
CR - Costa Rica 7
DK - Danimarca 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
AM - Armenia 6
KG - Kirghizistan 6
MD - Moldavia 6
NO - Norvegia 6
OM - Oman 6
SN - Senegal 6
AL - Albania 5
BH - Bahrain 5
EE - Estonia 5
LB - Libano 5
LV - Lettonia 5
MN - Mongolia 5
SK - Slovacchia (Repubblica Slovacca) 5
AO - Angola 4
BG - Bulgaria 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
KH - Cambogia 4
RS - Serbia 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CU - Cuba 3
CY - Cipro 3
Totale 24.378
Città #
Singapore 1.699
Chandler 1.168
Ashburn 978
San Jose 947
Frankfurt am Main 409
Munich 375
Dublin 333
Beijing 316
Jacksonville 294
San Mateo 266
New York 226
Jakarta 210
Ho Chi Minh City 209
Lauterbourg 203
Los Angeles 189
Warsaw 189
Wilmington 171
Hefei 168
Ann Arbor 161
Helsinki 161
Nanjing 156
Nürnberg 150
Tokyo 150
Hanoi 148
Boston 138
Hong Kong 138
Houston 125
Rome 125
São Paulo 116
Redmond 104
Chicago 99
Woodbridge 99
Princeton 97
Dallas 96
Dearborn 95
Milan 94
Moscow 90
Lawrence 72
Buffalo 66
Cattolica 66
Seattle 65
Fairfield 64
Nanchang 63
Redwood City 60
Santa Clara 59
Marseille 55
Bremen 52
Abidjan 50
Nuremberg 50
Kent 47
Rio de Janeiro 47
Seoul 46
Atlanta 45
Norwalk 45
Brooklyn 38
Paris 38
The Dalles 38
Baghdad 37
Brussels 37
Detroit 35
Hebei 35
Izmir 35
London 35
Johannesburg 34
Council Bluffs 33
Belo Horizonte 32
North Bergen 32
Orem 31
Vienna 31
Mountain View 30
Guangzhou 29
Pune 29
University Park 29
Düsseldorf 27
Kunming 26
Lappeenranta 26
Shanghai 26
Tianjin 26
Chennai 25
Haiphong 25
Leawood 25
Phoenix 25
Boardman 24
Da Nang 23
Shenyang 23
Dhaka 22
Turku 22
Salt Lake City 21
Tashkent 21
Toronto 21
Amman 20
Jiaxing 20
St Louis 20
Changsha 19
Denver 19
Hangzhou 19
Montreal 19
Stockholm 19
Brasília 18
Amsterdam 17
Totale 12.880
Nome #
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 399
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 315
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 264
Upper body involvement in GNE myopathy assessed by muscle imaging 264
Hospital admissions from the emergency department of adult patients affected by myopathies 257
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 253
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 250
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 248
Novel missense variants associated with GNE myopathy 243
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 238
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 235
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 197
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 195
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 194
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 193
Muscle imaging findings in GNE myopathy 190
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 186
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 185
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 184
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 183
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 179
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 176
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 173
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 172
A human anti-Neuronal Autoantibody Against GABAB Receptor induces Experimental Autoimmune Agrypnia 170
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 166
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle 164
A Case of Hemiabdominal Myoclonus 164
Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis 163
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene 163
Muscle MRI in female carriers of dystrophinopathy 163
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 163
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 157
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 157
TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis 156
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 154
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 152
Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy 152
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 150
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 150
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 148
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 147
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 146
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 146
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 144
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review 143
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 142
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 141
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 141
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 140
Acyclovir-related kidney injury during alemtuzumab infusion 137
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 137
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 136
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 135
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 134
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 134
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 134
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 134
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 131
A Case of Hemiabdominal Myoclonus 130
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 129
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 128
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 127
Relapsing-remitting autoimmune agrypnia 126
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 125
Coeliac disease presenting with acute disseminated encephalomyelitis. 123
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 123
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 123
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 122
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 121
Case of postpartum Parsonage-Turner syndrome 121
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 120
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 119
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 118
Coeliac disease presenting with acute disseminated encephalomyelitis 118
Bilateral thoracic long nerve involvement in motor multifocal neuropathy 118
ANCA-related vasculitic neuropathy mimicking motor neuron disease. 117
Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration 117
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 116
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients 116
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 116
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 116
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 115
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 114
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 114
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 114
A unique case of multiphasic ADEM or what else? 114
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 113
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 113
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 113
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 113
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 113
Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy 112
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 112
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 112
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 112
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 111
Chapter 28- Hereditary Inclusion-Body Myopathies 111
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 110
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients 110
Totale 15.382
Categoria #
all - tutte 100.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021309 0 0 0 0 0 0 0 0 0 0 280 29
2021/20221.616 135 100 33 197 50 59 46 250 97 84 245 320
2022/20233.242 383 432 266 466 226 431 149 276 390 49 123 51
2023/20241.648 62 466 60 120 53 224 115 70 24 57 181 216
2024/20253.898 79 99 308 144 205 206 249 242 629 291 821 625
2025/20269.187 1.408 282 612 1.039 1.664 767 1.603 484 637 620 71 0
Totale 24.734